This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Feb;7(2):115-6.

doi: 10.1016/S1474-4422(07)70330-7.

Intravenous immunoglobulin: a first-line treatment in CIDP?

Marinus Vermeulen

PMID: 18178526
DOI: 10.1016/S1474-4422(07)70330-7

Comment

Intravenous immunoglobulin: a first-line treatment in CIDP?

Marinus Vermeulen. Lancet Neurol. 2008 Feb.

. 2008 Feb;7(2):115-6.

doi: 10.1016/S1474-4422(07)70330-7.

Author

Marinus Vermeulen

PMID: 18178526
DOI: 10.1016/S1474-4422(07)70330-7

No abstract available

PubMed Disclaimer

Comment on

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA; ICE Study Group. Hughes RA, et al. Lancet Neurol. 2008 Feb;7(2):136-44. doi: 10.1016/S1474-4422(07)70329-0. Lancet Neurol. 2008. PMID: 18178525 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science